Sulbactam-based therapy for Acinetobacter baumannii infection: a systematic review and meta-analysis

Sulbactam-based therapy for Acinetobacter baumannii infection: a systematic review and meta-analysis

Show other versions (1)

Background: A number of studies have reported on the effectiveness of sulbactam-based therapies for Acinetobacter baumannii infection; however, there is little evidence that sulbactam-based therapies are more or less effective than alternative therapies. Unfortunately, there is a distinct lack of hi...

Full description

Bibliographic Details
Main Authors:	Haiqing Chu, Lan Zhao, Minggui Wang, Yang Liu, Tao Gui, Jingbo Zhang
Format:	Article
Language:	English
Published:	Elsevier 2013-07-01
Series:	Brazilian Journal of Infectious Diseases
Online Access:	http://www.sciencedirect.com/science/article/pii/S1413867013000718

Similar Items

Sulbactam-based therapy for Acinetobacter baumannii infection: a systematic review and meta-analysis
by: Haiqing Chu, et al.

Contribution of Acinetobacter-derived cephalosporinase-30 to sulbactam resistance in Acinetobacter baumannii
by: Shu-Chen eKuo, et al.
Published: (2015-03-01)

Comparison of Tigecycline or Cefoperazone/Sulbactam therapy for bloodstream infection due to Carbapenem-resistant Acinetobacter baumannii
by: Tianshui Niu, et al.
Published: (2019-03-01)

Synergistic effects of sulbactam in multi-drug-resistant Acinetobacter baumannii
by: Fatih Temocin, et al.
Published: (2015-12-01)

Investigation of sulbactam sensitivity rates in nosocomial Acinetobacter baumannii isolates by E-test
by: F. Temocin, et al.
Published: (2014-04-01)

Sulbactam Enhances in vitro Activity of β-Lactam Antibiotics Against Acinetobacter baumannii
by: Wang L, et al.
Published: (2021-09-01)

Sensitivity of levofloxacin in combination with ampicillin-sulbactam and tigecycline against multidrug-resistant Acinetobacter baumannii
by: Nahid Madadi-Goli, et al.
Published: (2017-05-01)

Determination of Susceptibility Rates of Nosocomial Acinetobacter baumannii Isolates to Sulbactam by E-test Method
by: Fatih Temoçin, et al.
Published: (2017-03-01)

Outcomes of Adjunctive Therapy with Intravenous Cefoperazone-Sulbactam for Ventilator-Associated Pneumonia Due to Carbapenem-Resistant Acinetobacter baumannii
by: Kanchanasuwan S, et al.
Published: (2021-03-01)

A New Twist: The Combination of Sulbactam/Avibactam Enhances Sulbactam Activity against Carbapenem-Resistant <i>Acinetobacter baumannii</i> (CRAB) Isolates
by: Fernando Pasteran, et al.
Published: (2021-05-01)

In vitro activity of cefoperazone and cefoperazone-sulbactam against carbapenem-resistant Acinetobacter baumannii and Pseudomonas aeruginosa
by: Lai CC, et al.
Published: (2018-12-01)

Study on longitudinal change of antibiograms and molecular epidemiology in Acinetobacter baumannii, and its mechanism of sulbactam resistance
by: Shu-Chen Kuo, et al.
Published: (2015)

Comparative efficacy and safety of combination therapy with high-dose sulbactam or colistin with additional antibacterial agents for multiple drug-resistant and extensively drug-resistant Acinetobacter baumannii infections: A systematic review and network meta-analysis
by: Jiating Liu, et al.
Published: (2021-03-01)

Pharmacodynamic profiling of optimal sulbactam regimens against carbapenem-resistant Acinetobacter baumannii for critically ill patients
by: Weerayuth Saelim, et al.
Published: (2018-01-01)

Overcoming addition of phosphoethanolamine to lipid A mediated colistin resistance in Acinetobacter baumannii clinical isolates with colistin–sulbactam combination therapy
by: Abe, S., et al.
Published: (2022)

Antimicrobial Susceptibility among Colistin, Sulbactam, and Fosfomycin and a Synergism Study of Colistin in Combination with Sulbactam or Fosfomycin against Clinical Isolates of Carbapenem-Resistant Acinetobacter baumannii
by: Sombat Leelasupasri, et al.
Published: (2018-01-01)

Clinical Experience with Tigecycline in Combination with Cefoperazon-Sulbactam for Ventilator Associated Pneumonia Caused by Multidrug-Resistant Acinetobacter baumannii
by: Nihal PİŞKİN, et al.
Published: (2012-06-01)

Bactericidal Effect of Sulbactam against Acinetobacter baumannii ATCC 19606 studied by 2D-DIGE and Mass Spectrometry
by: Lin, Cheng Hao, et al.
Published: (2015)

The minimal inhibitory concentration for sulbactam was not associated with the outcome of infections caused by carbapenem-resistant Acinetobacter sp. treated with ampicillin/sulbactam
by: Maura S. de Oliveira, et al.
Published: (2013-04-01)

A prospective evaluation of synergistic effect of sulbactam and tazobactam combination with meropenem or colistin against multidrug resistant Acinetobacter baumannii
by: Mohammed Ali M.Marie, et al.
Published: (2015-10-01)

Clinical Outcomes Of Colistin In Combination With Either 6-G Sulbactam Or Carbapenems For The Treatment Of Extensively Drug-Resistant Acinetobacter Baumannii Pneumonia With High MIC To Sulbactam, A Prospective Cohort Study
by: Ungthammakhun C, et al.
Published: (2019-09-01)

Comparative Metabolomics Reveals Key Pathways Associated With the Synergistic Killing of Colistin and Sulbactam Combination Against Multidrug-Resistant Acinetobacter baumannii
by: Mei-Ling Han, et al.
Published: (2019-07-01)

Study the binding of Sulbactam and AmpC beta-lactamase of Acinetobacter baumannii ATCC 19606 by MALDI-TOF MS and molecular modeling
by: Cheng, Kai-Wei, et al.
Published: (2016)

Investigation of the Synergic Effect of the Colistin/ Sulbactam Combination in Carbapenem-Resistant Acinetobacter baumannii complex Strains with Time-Kill and Checkerboard Methods
by: İmdat KILBAŞ, et al.
Published: (2021-03-01)

In vitro activity of sulbactam/durlobactam against extensively drug-resistant Acinetobacter baumannii isolates belonging to South American major clones
by: Carolina S. Nodari, et al.
Published: (2021-06-01)

Diagnosis of Acinetobacter Baumannii Infections
by: Hasan T Gozdas
Published: (2012-01-01)

A review on Acinetobacter baumannii
by: Xin Wang, et al.
Published: (2019-01-01)

Retrospective comparative analysis of risk factors and outcomes in patients with carbapenem resistant Acinetobacter baumannii bloodstream infections: cefoperazone–sulbactam associated with resistance and tigecycline increased the mortality
by: Niu T, et al.
Published: (2018-10-01)

Activity of Colistin in Combination with Meropenem, Tigecycline, Fosfomycin, Fusidic Acid, Rifampin or Sulbactam against Extensively Drug-Resistant Acinetobacter baumannii in a Murine Thigh-Infection Model.
by: Bing Fan, et al.
Published: (2016-01-01)

Pharmacodynamic assessment of Amoxicillin-Sulbactam against Acinetobacter baumannii: searching the optimal dose and infusion time through a human ex-vivo model
by: Carlos Bantar, et al.

Investigation of the Role of PBP1a, PBP1b and PBP3 on Antibacterial Mechanism of Sulbactam Against Acinetobacter baumannii ATCC 19606
by: Tseng, Pin Wen, et al.
Published: (2016)

Risk factors of Acinetobacter baumannii infections
by: E. Kucukler
Published: (2014-04-01)

Durlobactam, a New Diazabicyclooctane β-Lactamase Inhibitor for the Treatment of Acinetobacter Infections in Combination With Sulbactam
by: Adam B. Shapiro, et al.
Published: (2021-07-01)

Synergy effect of meropenem-based combinations against Acinetobacter baumannii: a systematic review and meta-analysis
by: Jiang Z, et al.
Published: (2018-08-01)

Comparison in a rat thigh abscess model of imipenem, meropenem and cefoperazone-sulbactam against <it>Acinetobacter baumannii </it>strains in terms of bactericidal efficacy and resistance selection
by: Gundes Sibel, et al.
Published: (2004-01-01)

Optimal Therapy for Multidrug-Resistant Acinetobacter baumannii
by: Burke A. Cunha, et al.
Published: (2010-01-01)

INFECTIONS CAUSED BY ACINETOBACTER BAUMANNII IN CANCER PATIENTS
by: N. V. Dmitrieva, et al.
Published: (2019-06-01)

Natural history of Acinetobacter baumannii infection in mice.
by: Brian M Luna, et al.
Published: (2019-01-01)

Clinical efficacy and safety of polymyxins based versus non-polymyxins based therapies in the infections caused by carbapenem-resistant Acinetobacter baumannii: a systematic review and meta-analysis
by: Cheng Lyu, et al.
Published: (2020-04-01)

Acinetobacter baumannii: problemático y además multirresistente Acinetobacter baumannii: problemátic and multiresistant
by: Guillermo PradaTrujillo
Published: (2006-06-01)